Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence.

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM.

J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):658-666. doi: 10.1016/j.jvsv.2017.03.016. Epub 2017 Jun 2.

PMID:
28818217
2.

Long-Term Clinical and Angiographic Outcomes Following Pipeline Embolization Device Treatment of Complex Internal Carotid Artery Aneurysms: Five-Year Results of the Pipeline for Uncoilable or Failed Aneurysms Trial.

Becske T, Brinjikji W, Potts MB, Kallmes DF, Shapiro M, Moran CJ, Levy EI, McDougall CG, Szikora I, Lanzino G, Woo HH, Lopes DK, Siddiqui AH, Albuquerque FC, Fiorella DJ, Saatci I, Cekirge SH, Berez AL, Cher DJ, Berentei Z, Marosfoi M, Nelson PK.

Neurosurgery. 2017 Jan 1;80(1):40-48. doi: 10.1093/neuros/nyw014.

PMID:
28362885
3.

Pipeline for uncoilable or failed aneurysms: 3-year follow-up results.

Becske T, Potts MB, Shapiro M, Kallmes DF, Brinjikji W, Saatci I, McDougall CG, Szikora I, Lanzino G, Moran CJ, Woo HH, Lopes DK, Berez AL, Cher DJ, Siddiqui AH, Levy EI, Albuquerque FC, Fiorella DJ, Berentei Z, Marosföi M, Cekirge SH, Nelson PK.

J Neurosurg. 2017 Jul;127(1):81-88. doi: 10.3171/2015.6.JNS15311. Epub 2016 Oct 14.

PMID:
27739944
4.

Two-Year Outcomes from a Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion vs. Non-Surgical Management for Sacroiliac Joint Dysfunction.

Polly DW, Swofford J, Whang PG, Frank CJ, Glaser JA, Limoni RP, Cher DJ, Wine KD, Sembrano JN; INSITE Study Group.

Int J Spine Surg. 2016 Aug 23;10:28. doi: 10.14444/3028. eCollection 2016.

5.

Productivity benefits of minimally invasive surgery in patients with chronic sacroiliac joint dysfunction.

Saavoss JD, Koenig L, Cher DJ.

Clinicoecon Outcomes Res. 2016 Apr 11;8:77-85. doi: 10.2147/CEOR.S101607. eCollection 2016.

6.

Triangular Titanium Implants for Minimally Invasive Sacroiliac Joint Fusion: A Prospective Study.

Duhon BS, Cher DJ, Wine KD, Kovalsky DA, Lockstadt H; SIFI Study Group.

Global Spine J. 2016 May;6(3):257-69. doi: 10.1055/s-0035-1562912. Epub 2015 Aug 11.

7.

Improvement in Health State Utility after Sacroiliac Joint Fusion: Comparison to Normal Populations.

Cher DJ, Polly DW.

Global Spine J. 2016 Mar;6(2):100-7. doi: 10.1055/s-0035-1556581. Epub 2015 Jun 25.

8.

Cost-effectiveness of minimally invasive sacroiliac joint fusion.

Cher DJ, Frasco MA, Arnold RJ, Polly DW.

Clinicoecon Outcomes Res. 2015 Dec 18;8:1-14. doi: 10.2147/CEOR.S94266. eCollection 2016. Erratum in: Clinicoecon Outcomes Res. 2016;8:305.

9.

Implant survivorship analysis after minimally invasive sacroiliac joint fusion using the iFuse Implant System(®).

Cher DJ, Reckling WC, Capobianco RA.

Med Devices (Auckl). 2015 Nov 23;8:485-92. doi: 10.2147/MDER.S94885. eCollection 2015.

10.

Letter: Industry Sponsorship of Spine Device Trials Is the Norm.

Cher DJ.

Neurosurgery. 2016 Mar;78(3):E475-6. doi: 10.1227/NEU.0000000000001134. No abstract available.

PMID:
26595431
11.

Quality of life in preoperative patients with sacroiliac joint dysfunction is at least as depressed as in other lumbar spinal conditions.

Cher DJ, Reckling WC.

Med Devices (Auckl). 2015 Sep 16;8:395-403. doi: 10.2147/MDER.S92070. eCollection 2015.

12.

Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion Using Triangular Titanium Implants vs Nonsurgical Management for Sacroiliac Joint Dysfunction: 12-Month Outcomes.

Polly DW, Cher DJ, Wine KD, Whang PG, Frank CJ, Harvey CF, Lockstadt H, Glaser JA, Limoni RP, Sembrano JN; INSITE Study Group.

Neurosurgery. 2015 Nov;77(5):674-90; discussion 690-1. doi: 10.1227/NEU.0000000000000988.

13.

Is the Oswestry Disability Index a valid measure of response to sacroiliac joint treatment?

Copay AG, Cher DJ.

Qual Life Res. 2016 Feb;25(2):283-292. doi: 10.1007/s11136-015-1095-3. Epub 2015 Aug 6.

14.

Neuroophthalmological outcomes associated with use of the Pipeline Embolization Device: analysis of the PUFS trial results.

Sahlein DH, Fouladvand M, Becske T, Saatci I, McDougall CG, Szikora I, Lanzino G, Moran CJ, Woo HH, Lopes DK, Berez AL, Cher DJ, Siddiqui AH, Levy EI, Albuquerque FC, Fiorella DJ, Berentei Z, Marosfoi M, Cekirge SH, Kallmes DF, Nelson PK.

J Neurosurg. 2015 Oct;123(4):897-905. doi: 10.3171/2014.12.JNS141777. Epub 2015 Jul 10.

PMID:
26162031
15.

Spine device clinical trials: design and sponsorship.

Cher DJ, Capobianco RA.

Spine J. 2015 May 1;15(5):1133-40. doi: 10.1016/j.spinee.2015.01.027. Epub 2015 Jan 28.

PMID:
25637470
16.

Pre-hysterectomy assessment of immediate tubal occlusion with the third-generation ESSURE insert (ESS505).

Thiel J, Rattray D, Cher DJ.

J Minim Invasive Gynecol. 2014 Nov-Dec;21(6):1055-60. doi: 10.1016/j.jmig.2014.04.020. Epub 2014 May 24.

PMID:
24861649
17.

Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence.

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM.

Phlebology. 2015 Jul;30(6):397-404. doi: 10.1177/0268355514532455. Epub 2014 Apr 30.

PMID:
24789750
18.

Safety and 6-month effectiveness of minimally invasive sacroiliac joint fusion: a prospective study.

Duhon BS, Cher DJ, Wine KD, Lockstadt H, Kovalsky D, Soo CL.

Med Devices (Auckl). 2013 Dec 13;6:219-29. doi: 10.2147/MDER.S55197. eCollection 2013.

19.

Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial.

Becske T, Kallmes DF, Saatci I, McDougall CG, Szikora I, Lanzino G, Moran CJ, Woo HH, Lopes DK, Berez AL, Cher DJ, Siddiqui AH, Levy EI, Albuquerque FC, Fiorella DJ, Berentei Z, Marosfoi M, Cekirge SH, Nelson PK.

Radiology. 2013 Jun;267(3):858-68. doi: 10.1148/radiol.13120099. Epub 2013 Feb 15.

PMID:
23418004
20.

Assessment of the beryllium lymphocyte proliferation test using statistical process control.

Cher DJ, Deubner DC, Kelsh MA, Chapman PS, Ray RM.

Inhal Toxicol. 2006 Oct;18(11):901-10.

PMID:
16864408
21.

Care management for low-risk patients with heart failure: a randomized, controlled trial.

DeBusk RF, Miller NH, Parker KM, Bandura A, Kraemer HC, Cher DJ, West JA, Fowler MB, Greenwald G.

Ann Intern Med. 2004 Oct 19;141(8):606-13.

PMID:
15492340
22.

MRI for detecting silicone breast implant rupture: meta-analysis and implications.

Cher DJ, Conwell JA, Mandel JS.

Ann Plast Surg. 2001 Oct;47(4):367-80.

PMID:
11601570
23.

Use of randomized controlled trials in organizational decision making: a cost-minimization approach.

Cher DJ, Maclure M.

Am J Manag Care. 2000 Aug;6(8):894-904. No abstract available.

24.
25.

Use of meta-analytic results to facilitate shared decision making.

Lenert LA, Cher DJ.

J Am Med Inform Assoc. 1999 Sep-Oct;6(5):412-9.

26.

Cellular telephone use and fatal traffic collisions: a commentary.

Cher DJ, Mrad RJ, Kelsh M.

Accid Anal Prev. 1999 Sep;31(5):599. No abstract available.

PMID:
10440557
27.

The effect of search procedures on utility elicitations.

Lenert LA, Cher DJ, Goldstein MK, Bergen MR, Garber A.

Med Decis Making. 1998 Jan-Mar;18(1):76-83.

PMID:
9456212
28.

Questioning decision analysis for treatment of clinically localized prostate cancer.

Cher DJ.

J Gen Intern Med. 1997 Oct;12(10):659. No abstract available.

29.

Method of Medicare reimbursement and the rate of potentially ineffective care of critically ill patients.

Cher DJ, Lenert LA.

JAMA. 1997 Sep 24;278(12):1001-7. Erratum in: JAMA 1998 Jun 17;279(23):1876.

PMID:
9307348
30.

Quantitative assessments from the clinical examination.

Cher DJ.

J Gen Intern Med. 1997 Aug;12(8):516-7. No abstract available.

31.
32.

Incorporating risk attitude into Markov-process decision models: importance for individual decision making.

Cher DJ, Miyamoto J, Lenert LA.

Med Decis Making. 1997 Jul-Sep;17(3):340-50.

PMID:
9219195
33.

Dietary calcium and blood pressure.

Cher DJ.

Ann Intern Med. 1997 Mar 15;126(6):492; author reply 492-3. No abstract available.

PMID:
9072942
34.

SecondOpinion: interactive Web-based access to a decision model.

Scott GC, Cher DJ, Lenert LA.

Proc AMIA Annu Fall Symp. 1997:769-73.

35.

Comorbidity and length of stay: statistically significant?

Cher DJ.

J Gen Intern Med. 1996 Aug;11(8):500. No abstract available.

PMID:
8872791
36.

A case of pelvic inflammatory disease associated with Neisseria meningitidis bacteremia.

Cher DJ, Maxwell WJ, Frusztajer N, Marin M, Wiviott LD.

Clin Infect Dis. 1993 Jul;17(1):134-5. No abstract available.

PMID:
8353234
37.

Colorectal cancer screening.

Cher DJ.

J Public Health Med. 1993 Jun;15(2):211-2. No abstract available.

PMID:
8353013
38.

Amylase release from streptolysin O permeabilized fetal pancreatic acini.

Cher DJ, Padfield PJ, Jamieson JD.

Am J Physiol. 1992 Apr;262(4 Pt 1):G719-26.

PMID:
1373567
39.

Supplemental Content

Support Center